(Q35064718)

6 August 2017

1 reference

title

A new role for SOCS in insulin action. Suppressor of cytokine signaling (English)

1 reference

6 August 2017

Danielle L Krebs

1

1 reference

6 August 2017

Douglas J Hilton

series ordinal

2

1 reference

6 August 2017

publication date

11 February 2003

1 reference

Science's STKE : signal transduction knowledge environment

6 August 2017

published in

1 reference

6 August 2017

volume

2003

1 reference

6 August 2017

issue

169

1 reference

6 August 2017

page(s)

PE6

1 reference

SOCS proteins: negative regulators of cytokine signaling

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

SOCS-3 is an insulin-induced negative regulator of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Mechanism of STAT3 activation by insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

The tumor suppressor activity of SOCS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.169.PE6

10.1126/STKE.2003.169.PE6

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference